Fabry disease trials in Canada
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
- Where
- Halifax, Montreal
- Age
- 18 years to 60 years
- People
- 16 worldwide
- Run by
- Idorsia Pharmaceuticals Ltd.
See details and how to joinNCT07778667 · EU 2026-525207-27-00 - No phaseTaking peopleFabry Disease Registry & Pregnancy Sub-registry
- Where
- Calgary, Edmonton, Halifax, Kingston, London, Moncton, Montreal, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
- People
- 9,000 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00196742 - No phaseTaking peopleFabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
- Where
- Toronto
- Age
- 18 years and over
- People
- 300
- Run by
- University Health Network, Toronto
See details and how to joinNCT04856059 - No phaseTaking peopleCanadian Fabry Disease Initiative (CFDI) National Registry
- Where
- Calgary, Halifax, Montreal, Toronto, Vancouver
- Age
- 5 years to 85 years
- People
- 600
- Run by
- Canadian Fabry Research Consortium
See details and how to joinNCT00455104